Insmed Statistics

Total Valuation

Insmed has a market cap or net worth of EUR 37.40 billion. The enterprise value is 36.59 billion.

Market Cap	37.40B
Enterprise Value	36.59B

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	213.27M
Shares Outstanding	n/a
Shares Change (YoY)	+22.43%
Shares Change (QoQ)	+11.86%
Owned by Insiders (%)	0.66%
Owned by Institutions (%)	91.22%
Float	191.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	98.16
PB Ratio	46.41
P/TBV Ratio	58.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-36.27
EV / Sales	95.23
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-47.38

Financial Position

The company has a current ratio of 4.63, with a Debt / Equity ratio of 0.78.

Current Ratio	4.63
Quick Ratio	4.18
Debt / Equity	0.78
Debt / EBITDA	n/a
Debt / FCF	-0.82
Interest Coverage	-11.81

Financial Efficiency

Return on equity (ROE) is -165.69% and return on invested capital (ROIC) is -37.18%.

Return on Equity (ROE)	-165.69%
Return on Assets (ROA)	-28.05%
Return on Invested Capital (ROIC)	-37.18%
Return on Capital Employed (ROCE)	-50.95%
Revenue Per Employee	299,761
Profits Per Employee	-793,851
Employee Count	1,271
Asset Turnover	0.20
Inventory Turnover	0.96

Taxes

In the past 12 months, Insmed has paid 4.04 million in taxes.

Income Tax	4.04M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +156.52% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+156.52%
50-Day Moving Average	119.18
200-Day Moving Average	82.02
Relative Strength Index (RSI)	75.27
Average Volume (20 Days)	31

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.87

Income Statement

In the last 12 months, Insmed had revenue of EUR 381.00 million and -1.01 billion in losses. Loss per share was -5.30.

Revenue	381.00M
Gross Profit	291.62M
Operating Income	-844.02M
Pretax Income	-1.00B
Net Income	-1.01B
EBITDA	-834.22M
EBIT	-844.02M
Loss Per Share	-5.30

Full Income Statement

Balance Sheet

The company has 1.43 billion in cash and 630.82 million in debt, giving a net cash position of 801.04 million.

Cash & Cash Equivalents	1.43B
Total Debt	630.82M
Net Cash	801.04M
Net Cash Per Share	n/a
Equity (Book Value)	805.91M
Book Value Per Share	3.79
Working Capital	1.29B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -752.92 million and capital expenditures -19.38 million, giving a free cash flow of -772.30 million.

Operating Cash Flow	-752.92M
Capital Expenditures	-19.38M
Free Cash Flow	-772.30M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 76.54%, with operating and profit margins of -221.53% and -264.83%.

Gross Margin	76.54%
Operating Margin	-221.53%
Pretax Margin	-263.77%
Profit Margin	-264.83%
EBITDA Margin	-218.96%
EBIT Margin	-221.53%
FCF Margin	n/a

Dividends & Yields

Insmed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.43%
Shareholder Yield	-22.43%
Earnings Yield	-2.70%
FCF Yield	-2.07%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Insmed has an Altman Z-Score of 3.4 and a Piotroski F-Score of 2.

Altman Z-Score	3.4
Piotroski F-Score	2